Catalyst
Slingshot members are tracking this event:
Phase 3 GWPCARE2 data of GW Pharmaceuticals'(GWPH) Epidiolex in Dravet Syndrome to be presented at AAN May 7, 2019
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 07, 2019
Occurred Source:
https://www.aan.com/siteassets/home-page/conferences-and-community/annual-meeting/abstracts-and-awards/2019-emerging-science-schedule-and-abstracts-with-disclosures.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Study, Gwpcare2, Epidiolex, Dravet Syndrome
